🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhuoxin “Zora” Zhou

The Ohio State University

ORCID: 0009-0006-2669-9595
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A Dual-Payload Antibody–Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer”.

A Dual-Payload Antibody–Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-4099
N/A
0.942DataRank · unranked
41 citations

Yingnan Si, Jiashuai Zhang, Kai Chen, Ashley George, Seulhee Kim +3 more

Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers

Pharmaceutics(2022)10.3390/pharmaceutics14010146
N/A
0.483DataRank · unranked
24 citations

Kai Chen, Hanh Giai Ngo, Jia Guan, Angela Totoro, Zhuoxin “Zora” Zhou +5 more

Correction: Chen et al. Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. Biomedicines 2022, 10, 130

Biomedicines(2023)10.3390/biomedicines12010086
N/A
0DataRank · unranked
8 citations

Yingnan Si, Jia-Shiung Guan, Zhuoxin “Zora” Zhou, Seulhee Kim, Tae Hyun Kim +5 more

Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma

Biomedicines(2022)10.3390/biomedicines10010130
N/A
0DataRank · unranked
25 citations

Yingnan Si, Jia-Shiung Guan, Zhuoxin “Zora” Zhou, Seulhee Kim, Tae Hyun Kim +5 more

Advanced biomanufacturing and evaluation of adeno-associated virus

Journal of Biological Engineering(2024)10.1186/s13036-024-00409-4
N/A
0DataRank · unranked
13 citations

Seulhee Kim, Siying Yang, Tanvi Varadkar, Zhuoxin “Zora” Zhou, Jiashuai Zhang +3 more

Anti-lipolysis-stimulated lipoprotein receptor antibody-drug conjugate to treat triple-negative breast cancer

Frontiers in Oncology(2025)10.3389/fonc.2025.1663743
N/A
0DataRank · unranked
1 citations

Davis Ballard, Tanvi Varadkar, Jiashuai Zhang, Zhenggui Du, Ashley George +5 more

Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer

Journal of Experimental & Clinical Cancer Research(2025)10.1186/s13046-025-03572-8
N/A
0DataRank · unranked
1 citations

Zhuoxin “Zora” Zhou, Jiashuai Zhang, Anusua Sarkar, Zhantao Du, Srijita Chowdhury +4 more